At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Autologous Regeneration of Tissue (ART) devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Autologous Regeneration of Tissue (ART) for Wound Healing
In Brief
A clinical study evaluating Autologous Regeneration of Tissue (ART) device for Wound of Skin. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The purpose of this research study is to learn about a new device, Autologous Regeneration of Tissue (ART), for collecting skin grafts from participant's own skin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWound of Skin
CountriesUnited States
CollaboratorsMedline Industries
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedJan 2019
Primary CompletionMar 2024
TodayJul 2026
First PostedJan 8, 2019
Enrollment StartSep 14, 2018
Primary CompletionMar 19, 2024
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 7.5 years ago
Interventions
Autologous Regeneration of Tissue (ART) devicedevice
This device will harvest hundreds of full-thickness columns of skin tissue (500 micrometer diameter) using single-needle, fluid-assisted harvesting technology.